Overview
Forxiga 5 mg Tablets contain Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus, heart failure, and chronic kidney disease. It helps lower blood glucose levels by promoting glucose excretion through urine. In addition to glycemic control, Forxiga supports cardiovascular and renal health, making it a valuable option for comprehensive metabolic care.





